Case Report
Combination Immunosuppressive Therapy in Primary Autoimmune Inner Ear Disease in Pregnancy
| Cerebrospinal fluid analysis |
| CSF glucose | 2.8 mmol/L | 2.2–3.9 | CSF protein | 0.43 g/L | 0.15–0.45 | CSF LDH | 24 U/L | | CSF cell count | Leukocytes | 36 × 106/L | | Erythrocytes | 2 × 106/L | | Polymorphonuclear cells | Nil | | Mononuclear cells | 36 × 106/L | | Oligoclonal bands | Positive, CSF restricted | | Culture | No bacterial growth | | Mycobacterial culture | Negative | | Mycobacterial NAT | Negative | | Nucleic acid testing for EBV, VZV CMV, enterovirus, HSV, and polyomavirus | Negative | | Cerebrospinal fluid immunologic tests | Neuronal antibodies: Purkinje (Yo), PCA 2, ANNA-1, ANNA-2, Ma 1, Ma 2, amphiphysin, CV2, Tr, SOX-1 | Negative | | NMDA receptor antibodies | Negative | | CASPR2 antibodies | Negative | | LGI-1 antibodies | Negative | | GABA-B antibodies | Negative | | DPPX antibodies | Negative | | IgLON5 antibodies | Negative | | Albumin | 0.21 g/L | 0–0.35 | Immunoglobulin G | 0.03 g/L | 0–0.03 | IgG/albumin ratio | 0.14 | 0–0.25 |
|
|